BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms

Bs Wyspiańska,Andrew J. Bannister,Isaia Barbieri,Jyoti Nangalia,Anna L. Godfrey,Fernando J. Calero-Nieto,Samuel C. Robson,I Rioja,Juan Li,M Wiese,Ester Cannizzaro,Mark A. Dawson,Brian J.P. Huntly,Rab K. Prinjha,Anthony R. Green,Berthold Göttgens,Tony Kouzarides

BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms

2014

Bs Wyspiańska
Andrew J. Bannister
Isaia Barbieri
Jyoti Nangalia
Anna L. Godfrey
Fernando J. Calero-Nieto
Samuel C. Robson
I Rioja
Juan Li
M Wiese
Ester Cannizzaro
Mark A. Dawson
Brian J.P. Huntly
Rab K. Prinjha
Anthony R. Green
Berthold Göttgens
Tony Kouzarides

The Kouzarides laboratory was supported by Cancer Research UK, Leukaemia and Lymphoma Research, GlaxoSmithKline and BBSRC. The Green laboratory was supported by Cancer Research UK and Leukaemia and Lymphoma Research, UK. The Gottgens laboratory was supported by Cancer Research UK and Leukaemia and Lymphoma Research, UK. The Huntly laboratory was supported by Cancer Research UK and Leukaemia and Lymphoma Research, UK. M. A Dawson, E Cannizzaro and M. Wiese are funded by the Wellcome Trust Beit Fellowship.

Keywords:

Cancer research
Lymphoma
Immunology
Medicine
Oncology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations